Compare · CDXS vs DD
CDXS vs DD
Side-by-side comparison of Codexis Inc. (CDXS) and DuPont de Nemours Inc. (DD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CDXS and DD operate in Major Chemicals (Industrials), so they compete in similar markets.
- DD is the larger of the two at $18.48B, about 90.8x CDXS ($203.6M).
- Over the past year, CDXS is down 21.5% and DD is down 40.6% - CDXS leads by 19.1 points.
- DD has hit the wire 4 times in the past 4 weeks while CDXS has been quiet.
- DD has more recent analyst coverage (25 ratings vs 12 for CDXS).
- Company
- Codexis Inc.
- DuPont de Nemours Inc.
- Price
- $2.23+3.00%
- $135.44+0.87%
- Market cap
- $203.6M
- $18.48B
- 1M return
- -10.08%
- -6.06%
- 1Y return
- -21.48%
- -40.59%
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2010
- 2017
- News (4w)
- 0
- 4
- Recent ratings
- 12
- 25
Codexis Inc.
Codexis, Inc. discovers, develops, and sells biocatalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.
DuPont de Nemours Inc.
DuPont de Nemours, Inc. provides technology-based materials, ingredients, and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. The company's Electronics & Imaging segment supplies materials to manufacture photovoltaics and solar cells; materials and printing systems to the advanced printing industry; and materials and solutions for the fabrication of semiconductors and integrated circuits addressing front-end and back-end of the manufacturing process. This segment also provides semiconductor and advanced packaging materials; dielectric and metallization solutions for chip packaging; and silicones for light emitting diode packaging and semiconductor applications; permanent and process chemistries for the fabrication of printed circuit boards to include laminates and substrates, electroless, and electrolytic metallization solutions, as well as patterning solutions, and materials and metallization processes for metal finishing, decorative, and industrial applications. In addition, it offers various materials to manufacture rigid and flexible displays for liquid crystal displays, advanced-matrix organic light emitting diode, and quantum dot applications. The Transportation & Advanced Polymers segment provides engineering resins, adhesives, silicones, lubricants, and parts to engineers and designers in the transportation, electronics, healthcare, industrial, and consumer end-markets. Its Safety & Construction segment provides engineered products and integrated systems for worker safety, water purification and separation, aerospace, energy, medical packaging, and building materials. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. is based in Wilmington, Delaware.
Latest CDXS
- SEC Form 8-K filed by Codexis Inc.
- SEC Form 4 filed by Director Parker H Stewart
- SEC Form 4 filed by Director Collins Cynthia
- SEC Form 4 filed by Director Richards Christos
- SEC Form 4 filed by Director Smith David V
- SEC Form 4 filed by Director Singhvi Rahul
- SEC Form 4 filed by Director Martinborough Esther
- SEC Form 4 filed by Director Dilly Stephen George
- SEC Form 4 filed by Director De Vre Raymond
- Director De Vre Raymond sold $6,174 worth of shares (2,605 units at $2.37), decreasing direct ownership by 3% to 84,811 units (SEC Form 4)
Latest DD
- DuPont Launches End-to-End Portfolio to Advance Direct Lithium Extraction
- DuPont Schedules Second Quarter 2026 Earnings Conference Call
- DuPont Launches Multi-Technology Water Treatment Design Tool
- McNICHOLS CO. Announces Appointment of Mateus Panosso as President
- DuPont de Nemours Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- DuPont Announces Regular Quarterly Dividend on Common Stock
- Goldman initiated coverage on DuPont with a new price target
- SEC Form 11-K filed by DuPont de Nemours Inc.
- DuPont Announces Healthcare Solutions U.S.-based Manufacturing Sites Now Powered by 100% Renewable Electricity
- DuPont™ MemCor™ MBR system selected for major Riverstone Water Resource Recovery Facility upgrade in Australia